WEDNESDAY, May 16 (HealthDay News) -- A preliminary, first-stage study funded by a pharmaceutical company shows promising results for an experimental double-drug therapy for melanoma.
The two drugs, known as dabrafenib and trametinib, appeared to delay progression of...
|
WEDNESDAY, May 16 (HealthDay News) -- Heart palpitations and high blood pressure are strong risk factors for a common heart rhythm disorder called atrial fibrillation, a new study reports.
Atrial fibrillation increases a person's risk of...
|
Sneezing, irritated skin, watery eyes -- it's springtime again, and allergy season is upon us.
